In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
A super new program at Housing Works helps participants get and keep their viral loads undetectable with incentives and without superpowers.
Documenting the Graying of AIDS
New treatment options for people living with HIV and hepatitis C
Behind the scenes of the Recollectors, a new advocacy group that brings together children who lost their parents to AIDS.
Michelangelo Signorile and Dan Savage discuss LGBT issues beyond marriage equality, including HIV/AIDS.
GMHC relaunches its historic support program—with unexpected twists.
In the 1980s, Tom Glenn cared for gay men dying of AIDS. Today he writes about that in ’No-Accounts.’
When Andrew Pulsipher announced his HIV-positive status on Facebook, he and his (HIV-negative) family became a viral sensation.
In St. Louis, the Doorways organization provides stable housing and health services for folks with HIV in the Show Me State.
Journalist Doug Ireland’s career spanned the AIDS epidemic and the gay rights movement.
What happens when an HIV campaign in Indiana takes a very wrong turn?
Writer-turned-activist Victoria Noe reflects on her initial decision to get involved in the early fight against HIV/AIDS
Longtime HIV/AIDS journalist and author John-Manuel Andriote reflects on GMHC’s relaunch of its Buddy Program earlier this year.
Researchers have finally produced evidence that starting antiretroviral treatment soon after an HIV diagnosis reduces the risk of sickness and...
Outside of convenience, the only major benefit of multi-antiretroviral combination tablets could be to pharmaceutical companies’ bottom line.
HIV-positive people who enjoy good psychological well-being are more likely to adhere to their antiretroviral regimen.
Opioid substitution treatment increases the likelihood that addicts will take their HIV antiretrovirals as prescribed.
Hepatitis C virus doesn’t significantly impact the risk of death unless it occurs along with other severe diseases.
A subdermal implant that delivers the HIV antiretroviral tenofovir alafenamide has shown promise as an alternative to daily PrEP in an animal...
A vaccine containing a protein key to HIV replication has been found to improve the effectiveness of antiretrovirals.
GSK (GlaxoSmithKline) has teamed up with the University of North Carolina at Chapel Hill to pursue HIV cure strategies.
The Centers for Disease Control and Prevention has issued an alert to public health departments and clinicians to be vigilant for HIV...
Most people living with HIV experience side effects from their HIV meds at one time or another.
September 2015 Survey
In many ways, Ashley Murphy is just a normal 17-year-old getting ready to start her senior year of high school. But she’s also a sassy young H...